Author . | Year . | Patients with AAI/DDD (n) . | Patients with VVI(R) (n) . | AF in AAI/ DDD pacing (% per year) . | AF in VVI pacing (% per year) . |
---|---|---|---|---|---|
Andersen et al.28 | 1997 | 110 | 115 | 4.1 | 6.6 |
Wharton et al.29 | 1998 | 100 | 98 | 48 | 43 |
Lamas et al.30 | 1998 | 203 | 204 | 6.9 | 7.5 |
Connolly et al.31 | 2000 | 1094 | 1474 | 5.3 | 6.6 |
Lamas et al.32 | 2002 | 1014 | 996 | 7.8 | 9.9 |
Kerr et al.33 | 2004 | (1014)a | (996)a | 4.5 | 5.7 |
Toff et al.34 | 2003 | 1012 | 1009 | b | b |
Wilkoff et al.35 | 2002 | 250 | 256 | 0 | 2.1 |
Total/mean | 3783 | 4152 | 6.6 | 7.8 |
Author . | Year . | Patients with AAI/DDD (n) . | Patients with VVI(R) (n) . | AF in AAI/ DDD pacing (% per year) . | AF in VVI pacing (% per year) . |
---|---|---|---|---|---|
Andersen et al.28 | 1997 | 110 | 115 | 4.1 | 6.6 |
Wharton et al.29 | 1998 | 100 | 98 | 48 | 43 |
Lamas et al.30 | 1998 | 203 | 204 | 6.9 | 7.5 |
Connolly et al.31 | 2000 | 1094 | 1474 | 5.3 | 6.6 |
Lamas et al.32 | 2002 | 1014 | 996 | 7.8 | 9.9 |
Kerr et al.33 | 2004 | (1014)a | (996)a | 4.5 | 5.7 |
Toff et al.34 | 2003 | 1012 | 1009 | b | b |
Wilkoff et al.35 | 2002 | 250 | 256 | 0 | 2.1 |
Total/mean | 3783 | 4152 | 6.6 | 7.8 |
a2002 patients of the CTOPP trial were eligible for the extended follow-up study.
bNo significant difference between AAI(R)/DDD(R) and VVI(R).
Author . | Year . | Patients with AAI/DDD (n) . | Patients with VVI(R) (n) . | AF in AAI/ DDD pacing (% per year) . | AF in VVI pacing (% per year) . |
---|---|---|---|---|---|
Andersen et al.28 | 1997 | 110 | 115 | 4.1 | 6.6 |
Wharton et al.29 | 1998 | 100 | 98 | 48 | 43 |
Lamas et al.30 | 1998 | 203 | 204 | 6.9 | 7.5 |
Connolly et al.31 | 2000 | 1094 | 1474 | 5.3 | 6.6 |
Lamas et al.32 | 2002 | 1014 | 996 | 7.8 | 9.9 |
Kerr et al.33 | 2004 | (1014)a | (996)a | 4.5 | 5.7 |
Toff et al.34 | 2003 | 1012 | 1009 | b | b |
Wilkoff et al.35 | 2002 | 250 | 256 | 0 | 2.1 |
Total/mean | 3783 | 4152 | 6.6 | 7.8 |
Author . | Year . | Patients with AAI/DDD (n) . | Patients with VVI(R) (n) . | AF in AAI/ DDD pacing (% per year) . | AF in VVI pacing (% per year) . |
---|---|---|---|---|---|
Andersen et al.28 | 1997 | 110 | 115 | 4.1 | 6.6 |
Wharton et al.29 | 1998 | 100 | 98 | 48 | 43 |
Lamas et al.30 | 1998 | 203 | 204 | 6.9 | 7.5 |
Connolly et al.31 | 2000 | 1094 | 1474 | 5.3 | 6.6 |
Lamas et al.32 | 2002 | 1014 | 996 | 7.8 | 9.9 |
Kerr et al.33 | 2004 | (1014)a | (996)a | 4.5 | 5.7 |
Toff et al.34 | 2003 | 1012 | 1009 | b | b |
Wilkoff et al.35 | 2002 | 250 | 256 | 0 | 2.1 |
Total/mean | 3783 | 4152 | 6.6 | 7.8 |
a2002 patients of the CTOPP trial were eligible for the extended follow-up study.
bNo significant difference between AAI(R)/DDD(R) and VVI(R).
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.